U.S. SEC Charges China Sky With Fraud In Nasdaq Stock Market Reports
This article was originally published in PharmAsia News
Executive Summary
A U.S. agency accused China Sky One Medical of committing fraud by claiming excess revenues as well as ties with a Malaysian distributor for its "slim-patch" weight-loss product.